These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3085290)

  • 1. Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model.
    Mast TJ; Cukierski MA; Nau H; Hendrickx AG
    Toxicology; 1986 May; 39(2):111-9. PubMed ID: 3085290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison.
    Hendrickx AG; Nau H; Binkerd P; Rowland JM; Rowland JR; Cukierski MJ; Cukierski MA
    Teratology; 1988 Oct; 38(4):329-45. PubMed ID: 3149039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of valproic acid on fetal and maternal organs in the mouse: a morphological study.
    Emmanouil-Nikoloussi EN; Foroglou NG; Kerameos-Foroglou CH; Thliveris JA
    Morphologie; 2004 Apr; 88(280):41-5. PubMed ID: 15208813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus.
    Eluma FO; Sucheston ME; Hayes TG; Paulson RB
    J Craniofac Genet Dev Biol; 1984; 4(3):191-210. PubMed ID: 6438150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
    Lin YL; Bialer M; Cabrera RM; Finnell RH; Wlodarczyk BJ
    Birth Defects Res; 2019 Aug; 111(14):1013-1023. PubMed ID: 30325584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice.
    Nau H; Löscher W
    Fundam Appl Toxicol; 1986 May; 6(4):669-76. PubMed ID: 3086174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.
    Fisher JE; Acuff-Smith KD; Schilling MA; Nau H; Vorhees CV
    Teratology; 1994 Jun; 49(6):479-86. PubMed ID: 7747269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats.
    Binkerd PE; Rowland JM; Nau H; Hendrickx AG
    Fundam Appl Toxicol; 1988 Oct; 11(3):485-93. PubMed ID: 3146521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen.
    Nau H
    Fundam Appl Toxicol; 1986 May; 6(4):662-8. PubMed ID: 3086173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryotoxicity of Norlestrin, a combined synthetic oral contraceptive, in rhesus macaques (Macaca mulatta).
    Prahalada S; Hendrickx AG
    Teratology; 1983 Apr; 27(2):215-22. PubMed ID: 6867943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratogenicity and developmental toxicity of valproic acid in rats.
    Vorhees CV
    Teratology; 1987 Apr; 35(2):195-202. PubMed ID: 3110992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Materno-fetal pharmacokinetics and fetal distribution of valproic acid in a pregnant rhesus monkey.
    Dickinson RG; Lawyer CH; Kaufman SN; Lynn RK; Gerber N; Novy MJ; Cook MJ
    Pediatr Pharmacol (New York); 1980; 1(1):71-83. PubMed ID: 6810290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid.
    Hauck RS; Nau H
    Toxicol Lett; 1989 Oct; 49(1):41-8. PubMed ID: 2510370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
    Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
    Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations.
    Nau H; Zierer R; Spielmann H; Neubert D; Gansau C
    Life Sci; 1981 Dec; 29(26):2803-14. PubMed ID: 6799722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.